Area of research
Oncology · Immunology
Research interest
Research interests include Medicine, Melanoma, Internal medicine, Disease, Immune system, and Cancer.
International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials
SEA-CD40, a non-fucosylated CD40 agonist: Interim results from a phase 1 study in advanced solid tumors.
Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma
Efficacy and safety of nilotinib in patients with KIT-mutated metastatic or inoperable melanoma: final results from the global, single-arm, phase II TEAM trial
Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992–2011
Immune checkpoint molecules soluble program death ligand 1 and galectin‐9 are increased in pregnancy
Development and External Validation of a Prognostic Nomogram for Metastatic Uveal Melanoma
Pilot Trial of Selecting Molecularly Guided Therapy for Patients with Non–V600 BRAF-Mutant Metastatic Melanoma: Experience of the SU2C/MRA Melanoma Dream Team
Pediatric melanoma: Analysis of an international registry